Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Novartis's Next-Gen Clinical Platform Enables AI Drug Development - SPS314

AWS Events via YouTube

Overview

Google, IBM & Meta Certificates – 40% Off
One Coursera Plus subscription covers most Professional Certificates on Coursera.
Unlock All Certificates
Explore how Novartis architected their regulated NextGen clinical trial data platform using AWS services in this 56-minute conference talk from AWS re:Invent 2025. Dive deep into their AWS-based clinical landscape implementation utilizing Amazon S3, Databricks on AWS, Amazon SageMaker, and AWS RDS to create a comprehensive data infrastructure. Discover their approach to data lake patterns and legacy system modernization while maintaining strict regulatory compliance requirements. Learn how they constructed a secure, traceable data backbone that powers AI and GenAI innovations across protocol design, trial performance management, and clinical document generation. Examine the architecture that enables clean data flow and rapid decision-making throughout drug development workflows, providing insights into how pharmaceutical companies can leverage cloud technologies to accelerate clinical research and drug discovery processes.

Syllabus

AWS re:Invent 2025 - Novartis's next-gen clinical platform enables AI drug development (SPS314)

Taught by

AWS Events

Reviews

Start your review of Novartis's Next-Gen Clinical Platform Enables AI Drug Development - SPS314

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.